Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Wednesday, September 2, 2026

Snapshot: Sep 2, 2026 · 6:00 PM 100 stocks analyzed

Flat Day

Wed, Sep 2, 2026 Divergent High

Divergent tape with high single-stock dispersion masks a modest broad decline as healthcare stocks surge while midcaps and small caps sink.

45% High dispersion and stock-picker volatility dominated the session, with 50 gainers averaging +26% (led by GELS +76%, GPRO +48% on merger news, BIAF +44% on clinical expansion) against 50 losers averaging -23% (EYES crashed -95%, ADBT -56% after failed IPO, TCRX -42% on restructuring), creating an extreme two-way market despite flat indices.
35% Broad-market weakness offset healthcare strength as S&P 500 fell 0.12%, Russell 2000 sank 1.75%, and S&P MidCap 400 dropped 1.99%, while NASDAQ Composite gained 0.34% on tech resilience; VIX ticked up 4.76% to 15.2, signaling modest risk-off without panic.
20% Healthcare dominance in gainers (32% of top 50, 12 stocks) versus balanced sector losses created a polarized tape; five debutant gainers (MNTK, VAI, EPRX, IRD, KCAC.WT) returned after long absences, suggesting tactical rotation into underowned names and small-cap opportunity hunting despite macro headwinds.

Healthcare drove 32% of gainers 5 names returned after long absences MNTK — first appearance VAI — first appearance

Market Regime

Wed, Sep 2, 2026 Neutral conf: medium macro · prototype

+19

Tailwind −100 … +100 · + tailwind / − headwind

VIX15.2 p14 Drawdown-1.7% Held2d · nascent SinceSep 1

Top drivers: VIX percentile ▲ S&P drawdown (60d) ▲ Small-cap leadership ▼

processId: history-market-regime

Market Indexes

Wed, Sep 2, 2026 13

S&P 500

7,666.60

−9.10

-0.12%

Dow Jones

53,061.95

−401.93

-0.75%

NASDAQ Composite

26,217.83

+87.63

+0.34%

NASDAQ 100

29,143.33

−81.19

-0.28%

DJ US Total Market

75,770.49

−253.88

-0.33%

Russell 1000

4,173.57

−12.04

-0.29%

S&P MidCap 400

3,746.44

−76.35

-2.00%

Russell 2000

2,953.17

−52.73

-1.75%

Russell 2500

1,260.70

+11.68

+0.94%

Russell 3000

4,354.73

−15.25

-0.35%

Nasdaq Financial-100

7,662.97

+61.65

+0.81%

NIFTY 50

23,914.45

−176.40

-0.73%

VIX

15.20

+0.69

+4.76%

Biggest Gainers

Wed, Sep 2, 2026 50

GELS

Gelteq Limited Ordinary SharesHealthcare

$0.69+$0.41

+76.3%

NASDAQ · Mkt cap $6.0 M

No news headlines were found in the last 48 hours to explain the 76% gain, so the catalyst remains unclear; the jump may reflect a delayed market reaction, technical bounce, or untracked announcement.

Yahoo Finance returned no headlines for Gelteq in the past 48 hours, making it impossible to attribute the dramatic 76% single-day rally to a specific corporate event such as earnings, FDA approval, partnership, or guidance revision. A stock trading at $0.69 on NASDAQ could be responsive to several types of catalysts that don't always receive broad news coverage: small-cap biotech or medical device companies often see sharp moves on trial results or regulatory decisions that may first appear in press releases or SEC filings rather than RSS feeds, shell companies or SPACs may spike on merger announcements, and highly illiquid penny stocks can gap up on low-volume technical rebounds or short covering. Without access to SEC filings, company press releases, or broader financial media beyond the limited RSS sample provided, the true cause cannot be pinpointed. The absence of any news headline is itself notable and suggests either a very recent development that hasn't yet propagated widely, a filing-based announcement, or a non-news market event.

DSX.WT

Diana Shipping Inc. WT

$1.05+$0.43

+68.0%

SZZL

Sizzle Acquisition Corp.Financial Services

$10.50+$3.58

+51.7%

NASDAQ · Mkt cap $327 M

No news headlines were found in the last 48 hours, so the 51.73% jump likely reflects either a delayed announcement, technical rebound, or market reaction to an event not yet captured by major financial news feeds.

The absence of any recent headlines makes it difficult to pinpoint a specific catalyst for SZZL's sharp 51.73% gain. However, as a SPAC (special purpose acquisition company), this stock is structurally prone to large single-day moves tied to merger announcements, de-SPAC timelines, shareholder votes, or redemption-related dynamics. SPACs also experience elevated retail and technical trading. The stock may have reacted to news released after the 48-hour window, an announcement from company filings not yet syndicated to Yahoo Finance RSS, or a technical bounce from oversold conditions. Without corroborating headlines, it is impossible to distinguish between fundamental news, a rumor, a short squeeze, or pure technical mean reversion.

GPRO

GoPro IncTechnology

$1.71+$0.56

+48.3%

NASDAQ · Mkt cap $117 M

GoPro surged 48% today following a $285 million merger agreement with Starman Optical announced on September 1st and reinforced by YouTube star Markiplier's 8.5% stake disclosure, which triggered a 128% two-day rally and positioned the company as an AI-focused optical-photonics player rather than…

The headline evidence is unambiguous: GoPro announced a definitive merger with Starman Optical on September 1st that values the deal at $285 million and involves a recapitalization where Starman will acquire a 90% stake while GoPro remains public. This announcement immediately triggered a 128% two-day surge, with Markiplier's disclosure of an 8.5% individual stake amplifying retail interest and media coverage. The merger frames GoPro's pivot from declining camera revenue and going-concern issues into AI infrastructure and optical-photonics, a narrative that resonates with growth-stage investors. The September 2nd continuation of the rally reflects continued momentum and positive sentiment around the transformation story, though the gains are partly distributed across two calendar days. Several headlines note GoPro was struggling with falling revenue and losses before the merger, suggesting the deal represents a material strategic reset rather than organic business improvement.

BIAF

bioAffinity Technologies, Inc. Healthcare

$9.77+$3.22

+44.0%

NASDAQ · Mkt cap $3.3 M

bioAffinity Technologies announced on September 1st that it is advancing its CyPath Lung test for a new application in post-treatment surveillance of lung cancer patients, a clinical expansion that likely drove investor enthusiasm and the 44% single-day gain.

The company released news on September 1st detailing an additional clinical application for its CyPath Lung diagnostic test, specifically for monitoring lung cancer survivors after treatment completion to detect recurrence or new primary cancers. This represents a potential expansion of the addressable market for an existing product already in clinical use. The announcement appears to have been well-received by the market, suggesting investors view the surveillance indication as a clinically meaningful and commercially valuable extension. However, the headlines do not specify concrete timelines, regulatory milestones, partnership deals, or financial guidance tied to this expansion, so the exact magnitude of commercial impact remains uncertain. The move is consistent with a small-cap biotech stock responding positively to pipeline advancement news.

LHAI

Linkhome Holdings Inc.Real Estate

$1.10+$0.35

+43.1%

NASDAQ · Mkt cap $12 M

Linkhome announced establishment of an AI computing subsidiary and is evaluating a European infrastructure project potentially involving up to 144 NVIDIA GB300 GPUs, sparking strong investor interest in the company's AI infrastructure pivot.

On September 2, 2026, Linkhome announced two related developments: formation of a wholly owned AI computing subsidiary called Linkhome Technologies and preliminary evaluation of a proposed European AI computing project that could deploy up to 144 NVIDIA GB300 GPUs. The headline explicitly notes no final investment decision has been made, indicating this is still in early evaluation stages. The timing of both announcements on the same day, combined with the specific mention of advanced NVIDIA hardware (the GB300 is a cutting-edge data center GPU), suggests Linkhome is repositioning itself as an AI infrastructure player. For a micro-cap stock trading at $1.10, structural exposure to the AI computing build-out thesis and concrete hardware deployment plans appear to have resonated strongly with investors seeking leverage to the GPU and data center infrastructure trend.

SWVL

Swvl Holdings Corp.

$5.10+$1.50

+42.0%

FAMI

Farmmi IncConsumer Defensive

$0.15+$0.04

+38.7%

NASDAQ · Mkt cap $3.9 M

No news headlines were found in the last 48 hours, so the 38.68% intraday gain is unexplained by any publicly reported catalyst. The jump likely reflects technical trading, retail sentiment, or delayed dissemination of off-venue information.

Farmmi Inc traded with no reported news catalyst in the Reuters, Yahoo Finance, or major wire service feeds during the snapshot window. A micro-cap stock like FAMI trading at $0.15 can experience outsized percentage moves on minimal volume or sentiment shifts. Possible categories of cause include technical mean reversion after a prior decline, short covering if the stock is heavily shorted and borrowed shares became scarce, retail social media coordination, options-related gamma effects near a strike price, or a company announcement that has not yet propagated to major news aggregators but has circulated through direct investor channels or social platforms. Without evidence of a specific business event, earnings release, contract win, or insider activity, the jump remains categorically unexplained by reportable corporate news.

LHSW

Lianhe Sowell International Group Ltd Ordinary SharesTechnology

$3.68+$1.03

+36.0%

NASDAQ · Mkt cap $9.6 M

Lianhe Sowell announced an $11 million follow-on public offering on September 2, which likely triggered the 35.95% surge as market participants reacted positively to the capital raise and growth signal.

The company announced a best-efforts follow-on public offering of $11 million on the morning of September 2, 2026. A 36% single-day jump following an offering announcement is unusual and typically suggests market optimism about either the company's use of proceeds, underlying business momentum, or a favorable market reception to the offering itself. The fact that this was a priced offering (not just a shelf registration) indicates real near-term capital deployment. For a China-based industrial machine vision company, new capital can signal expansion plans or working capital needs to support growth. However, the headline text provided was truncated and does not include details on the offering price, use of proceeds, or management commentary that would fully explain such a dramatic move. The jump could also reflect short covering or technical momentum given the stock's apparent recent volatility profile.

GYGY

Game Your Game, Inc.Technology

$1.74+$0.47

+34.6%

NASDAQ · Mkt cap $25 M

No news headlines were found in the last 48 hours for GYGY, so the 34.6% intraday jump cannot be attributed to a disclosed catalyst; the move likely reflects technical trading, retail momentum, or undisclosed company news.

The absence of any news in the Yahoo Finance RSS feed over the past 48 hours means we cannot point to an earnings report, product announcement, partnership, or guidance change as the cause of this significant gain. GYGY is a small-cap gaming company trading at $1.74, a price point and market capitalization that typically attract retail trader attention and higher volatility. The stock's ranking as the tenth-largest gainer of the day despite no visible news suggests either a delayed news release that has not yet propagated to major news feeds, technical buying pressure from chart-pattern recognition, or organic retail momentum in a micro-cap name. Without access to press releases, SEC filings, or social media chatter, we cannot determine which mechanism is at work here.

SBXD.WT

SilverBox Corp IV WT

$0.13+$0.03

+32.6%

FCUV

Focus Universal, Inc.Technology

$15.16+$3.66

+31.8%

NASDAQ · Mkt cap $5.7 M

No news headlines were found in the last 48 hours, so the 31.83% gain cannot be attributed to a specific announced catalyst. The jump was likely driven by technical factors, sector momentum, or information not captured in the Yahoo Finance RSS feed.

Focus Universal (FCUV) rose 31.83% on September 2, 2026, to rank twelfth among daily gainers, yet no news headlines appeared in the prior 48 hours on Yahoo Finance RSS. This disconnect between significant price action and public disclosure suggests the catalyst was either unreported in the RSS feed, based on technical or sentiment shifts, or tied to delayed dissemination of material news. For a micro-cap or lower-liquidity stock like FCUV, common drivers of large single-day rallies include short covering, options activity, sector rotation, analyst notes not yet widely syndicated, private placement announcements, or insider confidence signals. Without confirmed news, attributing the move to a specific event would be speculation.

GIPR

Generation Income Properties Inc.Real Estate

$0.39+$0.11

+31.7%

NASDAQ · Mkt cap $253 K

No news headlines were found in the last 48 hours, so the 31.68% gain likely reflects either a delayed market reaction to an older announcement, short-covering, or technical buying in a low-priced stock.

Generation Income Properties is a micro-cap equity with a stock price of $0.39, and no recent news is available to explain today's sharp jump to the number 13 position among daily gainers. In stocks trading at such low prices, moves of this magnitude can result from several mechanisms unrelated to fundamental news: short-squeeze activity as traders cover bearish positions, thin liquidity amplifying small order flows, or a reversal of previous weakness. Alternatively, a material announcement may exist but has not yet propagated to the Yahoo Finance RSS feed, or the move could reflect delayed market processing of an earlier development. Without confirmed recent news or structural insight into ongoing operations or capital events, identifying a specific catalyst is not possible.

AAC.WT

Ares Acquisition Corporation Re

$0.94+$0.22

+30.6%

BCSS.WT

Bain Capital GSS Investment Corp. WT

$0.80+$0.18

+28.8%

UFG

Uni-Fuels Holdings LimitedIndustrials

$0.56+$0.15

+28.5%

NASDAQ · Mkt cap $19 M

No news headlines were found in the last 48 hours for UFG, so the 28.47% gain likely reflects a technical bounce, delayed news pickup, or speculative trading in a low-priced stock.

The absence of any recent news headlines makes it impossible to identify a specific corporate catalyst for UFG's strong single-day gain. Micro-cap and penny stocks like UFG often experience volatile price swings driven by technical factors such as short covering, algorithmic trading, or retail investor attention rather than fundamental news. It is also possible that news occurred but has not yet been indexed by the RSS feed, or that the move was driven by sector rotation, broader market sentiment, or speculative positioning. Without concrete evidence of an announcement, earnings report, contract win, or other material event, any explanation remains speculative.

BIDWR

Tribeca Strategic Acquisition Corp. Rights

$0.13+$0.03

+27.8%

NYXH

Nyxoah S.A.Healthcare

$1.50+$0.43

+27.7%

NASDAQ · Mkt cap $165 M

Nyxoah's Genio system met primary safety and efficacy endpoints in its ACCCESS U.S. pivotal study for complete concentric collapse patients, driving a 27.74% share surge on positive clinical trial results.

Nyxoah announced that its ACCCESS U.S. pivotal study achieved primary endpoints for safety and efficacy in patients with complete concentric collapse, a specific anatomical phenotype of obstructive sleep apnea. The company reported a responder rate for the Apnea-Hypopnea Index, a key clinical measure of sleep apnea severity. This is a material clinical milestone for a medical device company seeking regulatory clearance. The stock gained 15% in immediate trading on the announcement and closed up 27.74%, suggesting either broader market enthusiasm beyond the initial reaction or additional positive detail release. For a smaller-cap device maker, successful pivotal trial endpoints typically justify significant revaluation as they reduce regulatory and commercial risk ahead of potential FDA approval and market launch.

NCPL

Netcapital Inc.Financial Services

$1.02+$0.22

+26.8%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours, so the 26.84% gain likely reflects either a delayed market reaction to an earlier announcement, technical trading activity, or information not yet captured in major news feeds.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst for NCPL's sharp 26.84% gain. Netcapital is a fintech platform focused on equity crowdfunding and alternative capital raising, and stocks in this category can be sensitive to several types of moves including updates to regulatory frameworks affecting crowdfunding, changes in platform metrics or user growth, insider transactions, or technical rebounds after oversold conditions. The stock's very low price of $1.02 suggests it may be thinly traded and susceptible to momentum or retail activity. Without verified news, the gain could also reflect a delayed market response to information released before the 48-hour window, or simply intraday volatility in a low-priced security.

AIEV

Thunder Power Holdings, Inc.Consumer Cyclical

$0.20+$0.04

+24.9%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours, so the 24.94% gain on Thunder Power Holdings likely reflects either a delayed market reaction to an earlier announcement, technical or short-covering activity, or an untracked catalyst.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for the move. Thunder Power Holdings is a small-cap stock trading at $0.20, which typically exhibits higher volatility and can be susceptible to technical factors, short squeezes, retail interest surges, or delayed reactions to news that may not be indexed by major news feeds. The stock's low price point and ranking as the 20th biggest gainer suggests momentum-driven interest rather than fundamental-driven movement. Without verifiable news, the gain could stem from a positive development announced earlier that the news aggregator missed, an intraday rumor or social media catalyst, improved technical setup after oversold conditions, or covering of short positions.

NDRA

ENDRA Life Sciences IncHealthcare

$6.35+$1.15

+22.1%

NASDAQ · Mkt cap $5.7 M

No news headlines were found in the last 48 hours, so the 22% intraday jump cannot be attributed to any reported event. The move likely reflects technical buying, short covering, or unreported developments.

ENDRA Life Sciences is a small-cap biotech company with limited liquidity, which can make it susceptible to outsized moves on light news or technical triggers. The absence of any Yahoo Finance headlines in the 48 hours preceding this 22% gain indicates the catalyst was not a major announcement covered by mainstream financial media. Possible explanations include a delayed press release not yet indexed by the RSS feed, short covering or momentum buying in a thinly traded stock, positive comments from an analyst or insider, pre-market clinical data expectations, or broader sector rotation into biotech. Without access to the company's actual news release timing, regulatory filings, or internal trading patterns, attribution remains speculative. Small-cap biotech stocks commonly exhibit large daily swings on research developments, clinical trial updates, or partnership announcements even when immediate news coverage lags.

CYAN

Cyanotech CorpConsumer Defensive

$0.51+$0.09

+21.4%

NASDAQ · Mkt cap $3.3 M

No news headlines were found in the last 48 hours, so the 21.43% jump in CYAN stock cannot be attributed to a specific announced catalyst. The move likely reflects technical trading, market sentiment, or undisclosed information.

Cyanotech is a small-cap bioproducts company, and without any recent news coverage in the provided sources, there is no factual basis to link the stock's sharp 21.43% gain to a concrete corporate event like earnings, product approval, partnership, or guidance change. Small-cap stocks trading at $0.51 are typically sensitive to technical factors, short covering, retail interest surges, and broader sector momentum shifts that may or may not be visible in mainstream financial news feeds. It is also possible that news was distributed through channels not captured in the Yahoo Finance RSS feed provided, or that the move reflects delayed market reaction to an older announcement. Without headline evidence, any explanation remains speculative.

TLYS

Tilly's IncConsumer Cyclical

$3.85+$0.90

+21.3%

NYSE · Mkt cap $114 M

Tilly's reported Q2 earnings that beat Wall Street estimates by 58.82% on earnings and 4.14% on revenue, with sales up 8.1% year-over-year and third consecutive quarter of double-digit comp sales growth, driving a 21.28% stock gain.

Tilly's (TLYS) released Q2 fiscal 2026 results on September 2, 2026, that significantly exceeded analyst expectations. The young adult apparel retailer delivered earnings per share that beat by nearly 59% and revenue that surpassed estimates by over 4%, with total Q2 sales reaching $163.5 million. More importantly, the company achieved its third consecutive quarter of double-digit percentage comp sales increases, signaling sustained momentum in a sector that has faced retail headwinds. One headline mentioned stock jumped 31.4%, slightly higher than the current snapshot of 21.28%, possibly reflecting post-market versus closing-price differences. The combination of a large earnings beat, strong year-over-year growth, and consistent sequential comp sales outperformance is a classic fundamental catalyst for a retail stock trading at a low price point like $3.85.

MNTK

Montauk Renewables, Inc.

$2.14+$0.38

+21.2%

BNCWW

CEA Industries Inc. WarrantIndustrials

$0.02+$0.00

+20.8%

NASDAQ

No news was found in the last 48 hours to explain the 20.81% gain in BNCWW, a warrant trading at $0.02. The move is most likely driven by technical factors, volatility in the underlying CEA Industries stock, or warrant-specific mechanics in a thinly traded security.

BNCWW is a warrant, a leveraged derivative that amplifies price moves in the underlying common stock. Warrants are highly sensitive to small percentage swings in their underlying and can experience large percentage moves on minimal absolute price changes, especially when trading at very low prices near $0.02 where even a fractional cent movement translates to double-digit percentage gains. With no news identified in the last 48 hours, the catalyst was likely either a modest move in the CEA Industries common stock that got amplified through warrant mechanics, technical trading activity in the warrant itself, or delayed market reaction to older announcements. Thinly traded warrant securities are prone to outsized moves on low volume and limited liquidity.

CABO

Cable One IncCommunication Services

$28.52+$4.79

+20.2%

NYSE · Mkt cap $147 M

Cable One (CABO) surged 20.19% on a modest operational update from its Sparklight subsidiary regarding wholesale connectivity ordering enhancements, though the magnitude of the move suggests broader market forces or delayed news reaction may have driven the gain.

The sole headline provided details a service improvement by Sparklight Carrier Services related to wholesale ordering integration with TransUnion's Universal Order Connect platform. This is an operational efficiency announcement rather than a transformative business event, earnings beat, or strategic pivot. A 20% single-day rally on a routine connectivity ordering streamline would be disproportionate unless investors had been anticipating this announcement or the stock was significantly undervalued prior to the move. The headline itself lacks specifics on revenue impact, customer wins, or competitive implications. Cable One is a regional cable and broadband provider operating under the Sparklight brand, and wholesale carrier services are a modest revenue segment. Without additional context on market sentiment, short interest, or other catalysts released on September 2, 2026, the connection between this operational update and a top-26 gainer ranking remains unclear.

CURR

CURE Pharmaceutical Holding Corp.Financial Services

$4.06+$0.68

+19.9%

PMI

Picard Medical, Inc.Healthcare

$4.63+$0.75

+19.3%

NYSE · Mkt cap $6.8 M

A ticker mismatch exists—the news references Philip Morris International (ticker PM), not Picard Medical (PMI). The +19.27% jump in PMI lacks any identified catalyst in the provided headlines and likely stems from an unrelated driver such as technical trading, sector rotation, or micro-cap volati…

The headline provided discusses Philip Morris International's CEO hosting a fireside chat at a consumer conference. However, Philip Morris International trades under the ticker PM on NYSE, not PMI. Picard Medical (PMI) is a separate security and receives no mention in the news provided. Without relevant headlines tied to Picard Medical, we cannot ground the explanation in a specific event. Small-cap and micro-cap stocks like PMI often exhibit sharp single-day moves driven by thin float, momentum trading, retail attention, or technical breakouts rather than fundamental news. The 19.27% gain could reflect accumulated buying pressure, a short squeeze, or sector tailwinds in healthcare or medtech, but these remain speculative absent direct evidence.

VAI

Valor Energy Incorporated

$2.00+$0.32

+18.8%

RNXT

RenovoRx, Inc.

$2.51+$0.40

+18.7%

EOSE

Eos Energy Enterprises IncIndustrials

$3.63+$0.55

+17.9%

NASDAQ · Mkt cap $1.3 B

Eos Energy Enterprises announced a major collaboration with Google and MN8 Energy to supply energy storage systems for a West Virginia solar project and Google data centers, driving a 17.92% gain on strong commercial validation.

The news headlines establish a clear and material catalyst: Eos Energy secured a partnership with Google, one of the world's largest technology companies, to supply zinc-based long-duration energy storage systems for both a utility-scale solar project in West Virginia and Google data center operations. This represents significant commercial traction for the company's core product line. The announcement was released on September 2, 2026, and the stock rose 12% initially following the West Virginia project news, then jumped further to 17.92% by day's end as the Google data center supply deal gained broader market attention. For an energy storage company, securing a named tier-one customer like Google validates both product technology and market demand, reduces execution risk, and signals potential for future orders. The stock's strong response reflects investor recognition that this partnership enhances revenue visibility and competitive positioning in the rapidly growing data center power backup and grid storage markets.

TGHL

The GrowHub Limited Class A Ordinary SharesTechnology

$0.90+$0.14

+17.7%

NASDAQ · Mkt cap $17 M

No news headlines were found in the last 48 hours to explain TGHL's 17.69% jump on September 2, 2026. The cause remains unknown without additional information.

The absence of recent news is notable for a stock posting a significant single-day gain of nearly 18 percent. For a small-cap company like TGHL trading at $0.90, such moves can be driven by several typical catalysts: short covering or technical oversold rebounds, retail trading activity concentrating on low-priced stocks, insider activity or unannounced developments, or delayed market reaction to older news that did not appear in the RSS feed capture window. Without access to intraday volume data, market sentiment shifts, or company filings, it is difficult to pinpoint the specific trigger. The lack of discoverable headlines suggests either the catalyst is non-news-based (technical or sentiment-driven) or relevant announcements simply did not appear in the available news sources during the specified timeframe.

EPRX

Eupraxia Pharmaceuticals Inc.

$7.44+$1.11

+17.5%

CNTB

Connect Biopharma Holdings LimitedHealthcare

$2.77+$0.40

+16.9%

NASDAQ · Mkt cap $155 M

No news headlines were found in the last 48 hours, so the 16.88% gain likely reflects either a delayed market reaction to an earlier announcement, a biotech sector rally, or technical trading activity rather than a fresh catalyst.

The absence of recent news headlines makes it difficult to pinpoint a specific fundamental driver for this 16.88% intraday gain. Connect Biopharma is a clinical-stage biopharmaceutical company, and stocks in this category typically respond sharply to clinical trial results, regulatory decisions, partnership announcements, or financing events. Given the magnitude of the move and its rank as the 34th biggest gainer, the catalyst could be a pre-market or overnight development not yet indexed in the Yahoo Finance RSS feed, a reversal of prior short positioning, broad biotech sector strength, or an announcement from earlier in the week that is only now gaining traction. Without access to the actual news, we cannot distinguish among these possibilities with confidence.

XTNT

Xtant Medical Holdings IncHealthcare

$0.42+$0.06

+16.8%

NYSE · Mkt cap $46 M

No news headlines were available in the last 48 hours, so the 16.82% gain cannot be attributed to a specific disclosed event. The move likely reflects technical trading, delayed news pickup, or market-wide microstructure in a micro-cap stock.

Xtant Medical is a micro-cap orthopedic and regenerative medicine company trading at $0.42, and no substantive news was published in the most recent 48 hours according to the provided RSS feed. This presents a classic challenge in explaining moves in very small-cap stocks: they are prone to low-volume rallies driven by short covering, retail interest, stale news finally circulating, or sector rotation rather than fresh catalysts. Given the stock's size and the absence of headlines, the most likely causes fall into three categories: technical rebound from oversold levels, a delayed market reaction to news from earlier in the week that has not yet reached major financial news aggregators, or modest short-squeeze activity typical of thinly traded names. Without access to intraday volume data, trading halts, or broker circulation of research, we cannot pinpoint the specific trigger.

IRD

Opus Genetics, Inc.Healthcare

$4.47+$0.64

+16.6%

NASDAQ · Mkt cap $302 M

Opus Genetics rose 16.56% following announcement that it will present Phase 1/2 clinical data for its OPGx-BEST1 gene therapy on September 9, building on pre-market momentum from the prior day's 5.9% gain ahead of the data release.

The headlines establish two related catalysts. On September 1, shares rose 5.9% in pre-market trading in anticipation of topline data from Cohort 1 of the OPGx-BEST1 Phase 1/2 trial. On September 2, the company formally announced it would present that same clinical dataset during an investor webcast and conference call on September 9, plus additional analyses at leading ophthalmology conferences. The 16.56% gain on September 2 appears to reflect sustained investor interest in the upcoming data release combined with confirmation of the presentation format and venue. For clinical-stage biotech companies, upcoming data presentations—particularly those involving in-vivo gene therapy programs for rare eye diseases—typically drive significant near-term volatility as investors assess efficacy and safety signals. The staggered pre-announcement followed by formal presentation notice created two catalysts within 48 hours.

NBRGR

Newbridge Acquisition Limited Rights

$0.23+$0.03

+16.5%

NASDAQ

No news headlines were found in the last 48 hours, so the 16.46% gain on NBRGR likely reflects a technical or liquidity-driven move typical of low-priced SPAC rights securities, or reaction to delayed news not yet syndicated to Yahoo Finance.

Newbridge Acquisition Limited Rights is a SPAC rights offering security, a class of instrument that typically trades at low absolute prices with high percentage volatility even on modest dollar moves. The absence of headlines from major financial news feeds in the prior 48 hours means we cannot identify a specific catalyst such as merger news, shareholder votes, or redemption deadline announcements. SPAC rights can spike on several types of triggers: a confirmed merger date or terms announcement, a shareholder vote outcome, expiration or redemption deadlines, or shifts in sentiment about the underlying acquisition target. Alternatively, the move could reflect technical factors such as short covering, options-driven positioning, or a delay in news dissemination to the RSS feed. Without access to company filings or real-time alerts, attributing this move to any specific event would be speculative.

CTSO

CytoSorbents CorpHealthcare

$0.39+$0.05

+16.1%

NASDAQ · Mkt cap $24 M

CytoSorbents announced positive real-world data showing significant bleeding reduction using CytoSorb in cardiac surgery patients on ticagrelor, plus updates on FDA pre-submission meetings for DrugSorb-ATR, driving the 16% single-day gain.

The company released independent patient-level data demonstrating clinical efficacy of its blood purification technology in reducing severe bleeding complications during coronary artery bypass grafting in patients receiving dual antiplatelet therapy. This represents direct evidence of therapeutic benefit in a high-acuity clinical setting. Simultaneously, CytoSorbents reported progress on its DrugSorb-ATR program through recent FDA pre-submission meetings, signaling regulatory pathway advancement. For a small-cap medical device company trading near $0.39, clinical validation data combined with regulatory progress typically generates meaningful investor enthusiasm, particularly if prior results were uncertain or if the market had been positioned pessimistically. The timing of dual positive developments on the same announcement day amplified the rally.

DELL

Dell Technologies IncTechnology

$492.18+$67.82

+16.0%

NYSE · Mkt cap $374 B

Dell reported better-than-expected Q2 fiscal 2027 earnings on September 2nd after market close, driven by a $95 billion AI server backlog and record ISG revenues, prompting the 16% surge as the stock reclaimed a technical breakout level.

The headlines establish a clear earnings catalyst. Dell posted Q2 results that beat Wall Street expectations, with AI server demand tripling and ISG revenues hitting record levels. Management raised full-year guidance, and the company disclosed a $95 billion AI backlog, signaling strong order conversion visibility ahead. While one analyst note flagged potential AI growth slowdown concerns and another maintained a Hold rating despite "phenomenal" results, the consensus across headlines emphasizes broad-based strength and the company's market leadership in the AI infrastructure boom. The 16% single-day gain reflects investor relief and enthusiasm around both the beat itself and the company's continued positioning as a beneficiary of data center expansion driven by generative AI adoption.

YDES

YD BIO LIMITEDHealthcare

$3.90+$0.58

+15.9%

NASDAQ · Mkt cap $317 M

YD Bio reported unaudited financial results for H1 2026 on August 31st, likely triggering the 15.89% gain on September 2nd as investors digested the earnings release and reassessed the biotech company's progress in cancer detection and ophthalmologic technology development.

YD Bio released unaudited financial results for the six months ended June 30, 2026, on August 31st, and the stock surged approximately 16% the following trading day. The headline confirms a material corporate event occurred within the critical 48-hour window before the price move. The press release mentions the company's focus on DNA methylation-based cancer detection technology and ophthalmologic innovation, suggesting active development in two therapeutic areas. However, the headline provided is truncated and does not disclose specific financial metrics, earnings surprises, guidance updates, or clinical milestones that would formally explain investor enthusiasm. The timing and magnitude of the move align with earnings-driven volatility, but without access to the full earnings content—revenue figures, profitability, cash position, pipeline updates—we cannot definitively confirm whether results beat expectations, missed, or simply restored confidence in execution.

Definitive Healthcare Corp.Healthcare

$1.05+$0.14

+15.9%

NASDAQ · Mkt cap $77 M

Definitive Healthcare shares rose 15.87% after Advent International submitted a non-binding $1.02-per-share going-private proposal, with the board's special committee confirming receipt of the offer on the same day.

The stock's 15.87% jump is directly attributable to the going-private proposal from Advent International at $1.02 per share, announced on September 2, 2026. The prior-day close is not provided, but the $1.05 current price sits slightly above the $1.02 offer, which is typical when markets price in execution risk or potential for a higher bid. The simultaneous announcement of a new CEO appointment (Clay Ritchey, with 25+ years of healthcare experience) reinforces management stability during the acquisition process. The special committee's formal confirmation of receipt validates the legitimacy of the proposal. Investors are bidding the stock up because the offer provides a known floor value and signals strategic interest from a major private equity investor, reducing uncertainty for a previously illiquid or underperforming public stock.

KRSP.WT

$1.04+$0.14

+15.6%

SORA

Top Win International LimitedConsumer Cyclical

$2.40+$0.32

+15.4%

NASDAQ · Mkt cap $57 M

No news headlines were found in the last 48 hours for SORA, making the 15.38% gain unexplained by any disclosed catalyst. The jump likely reflects either technical momentum, delayed market reaction to an untracked event, or sector-driven trading.

The absence of news in Yahoo Finance's RSS feed over the last two days means we cannot attribute this gain to earnings, guidance, partnerships, or other fundamental announcements. For a small-cap stock like Top Win International, several generic drivers could explain an intraday 15% move: short covering if the stock was previously shorted, technical oversold condition bouncing back, options expiration effects, or momentum trading in a thinly traded name. Without access to institutional news services, SEC filings, or real-time social media discussion, we lack visibility into whether a meaningful corporate event occurred but simply was not captured by the Yahoo Finance feed, or whether the move is purely technical-driven. The rank as the 43rd biggest gainer suggests it was a notable move but offers no causal insight.

DLXY

Delixy Holdings LimitedEnergy

$0.44+$0.06

+15.3%

NASDAQ · Mkt cap $6.6 M

No news headlines were found in the last 48 hours, so the 15.27% gain cannot be attributed to a specific announced catalyst. The move likely reflects technical trading, retail interest, or untracked company developments.

The absence of recent news in the Yahoo Finance RSS feed means we cannot point to earnings, guidance, regulatory action, or M&A as the driver. DLXY is a micro-cap stock trading at $0.44, a profile typical of penny stocks that can experience outsized moves on minimal volume, technical chart patterns, short covering, or social media interest. Without visibility into news sources beyond the RSS feed provided, we cannot rule out that a company announcement or industry development occurred but simply was not captured in the headlines supplied. The jump into the top 50 gainers suggests real trading activity rather than a data error, but the specific catalyst remains unknown.

AHPA

Avista Public Acquisition Corp. II

$5.04+$0.66

+15.1%

AIMD

Ainos, Inc.Technology

$1.58+$0.21

+14.9%

NASDAQ · Mkt cap $11 M

No headlines were found in the last 48 hours for AIMD, so the 14.91% gain cannot be attributed to a specific reported catalyst. The jump may reflect technical trading, delayed news dissemination, or market rumors.

The absence of recent Yahoo Finance headlines for AIMD during the 48-hour window preceding this 14.91% rally makes it impossible to identify a confirmed news-based catalyst. For a micro-cap or thinly traded stock like this, significant price moves often occur due to technical factors such as short covering, algorithmic trading on low volume, or delayed reporting of material events. Alternatively, the catalyst could be an unverified rumor circulating among retail traders or a press release not yet indexed by the RSS feed. Without access to real-time trading data, order flow, or company-specific announcements outside the provided news sources, determining the true driver remains speculative.

RITR

Reitar Logtech Holdings Limited Ordinary sharesIndustrials

$0.10+$0.01

+14.8%

NASDAQ · Mkt cap $4.8 M

Reitar announced elimination of $2.2 million in convertible notes debt on September 1st and a major strategic partnership with Cainiao on September 2nd, both positive catalysts that likely drove the 14.83% rally by removing financing overhang and signaling growth momentum.

The stock's strong gain coincides with two material announcements released within 48 hours. The elimination of all outstanding convertible notes removes a legacy financing burden and de-risks the capital structure, preserving cash for operations and growth. This was coupled on September 2nd with news of a strategic partnership between Reitar's Jingxing unit and Cainiao involving smart warehouse projects in Spain and the Netherlands entering delivery phase, plus a planned $30 million automated cold-storage facility in North America. Both announcements target positive sentiment: debt reduction addresses balance-sheet concerns common among penny stocks, while new partnership revenue and geographic expansion suggest operational momentum. Given the stock trades at $0.10, even modest positive news can produce outsized percentage gains, but these headlines provide substantive fundamental reasons beyond pure technical movement.

SLBT

SL Science Holding LimitedHealthcare

$3.32+$0.41

+14.8%

NASDAQ · Mkt cap $1.8 B

SL Science Holding Limited rang the NASDAQ bell to mark its active first quarter as a publicly traded company on September 2, 2026, which likely drove sentiment and retail interest in the newly listed biomedical stock.

The headline establishes that SL Science held a bell-ringing ceremony on the date of the price surge, marking a milestone in the company's early public trading history. Bell-ringing events are typically ceremonial occasions that generate publicity and can attract retail investor attention, particularly for recently IPO'd companies still in their first quarter of public trading. The company is a Taiwan-headquartered biomedical firm focused on cellular and gene therapy, sectors that have historically attracted speculative interest. However, the headline does not disclose specific business results, clinical data, partnerships, or financial guidance that would objectively justify the 14.76% gain. The move may reflect general positive sentiment around the company's successful transition to public markets and early trading activity, though without earnings data or operational announcements, the mechanical driver remains unclear and may include technical factors or broader market conditions not captured in the provided headline.

FLD

FTAC Emerald Acquisition Corp.Financial Services

$0.46+$0.07

+14.6%

NASDAQ · Mkt cap $25 M

No news headlines were found in the last 48 hours, so the 14.55% gain on FLD cannot be attributed to a specific reported catalyst. The move is likely driven by technical trading, a delayed announcement, or merger/acquisition speculation typical of SPACs.

FTAC Emerald Acquisition Corp. is a special purpose acquisition company (SPAC), and the absence of recent news makes direct attribution impossible. SPACs historically exhibit high volatility driven by factors other than traditional earnings or business announcements: short covering, options expiration mechanics, rumors of an imminent merger agreement, or shifts in redemption sentiment ahead of a deadline can all trigger sharp single-day moves. At $0.46, the stock is trading near or below its typical SPAC trust value floor, which suggests the gain may reflect either renewed merger confidence or technical accumulation. Without a headline explaining the specific catalyst, any conclusion about cause remains speculative and should be treated as such.

ATER

Aterian, Inc.Consumer Cyclical

$0.51+$0.06

+14.5%

NASDAQ · Mkt cap $5.0 M

No news headlines were found in the last 48 hours, so the 14.46% gain on ATER likely reflects technical trading, short covering, or undetected rumors rather than a major announced catalyst.

Aterian Inc. is a small-cap stock trading at $0.51 with no identifiable news catalyst in the provided 48-hour window. A 14.46% intraday jump on a stock at this price level and market cap typically reflects one of several patterns: short squeeze activity if the stock had elevated short interest, technical rebound from oversold conditions, retail momentum or social media discussion, or delayed market reaction to a news item not yet indexed by Yahoo Finance RSS. Without headline evidence, it is reasonable to infer this could be technical mean reversion or momentum play common among penny stocks, but this remains speculation. The absence of news combined with the outsized percentage move is notable and warrants verification through real-time trading data or investor forums to rule out after-hours announcements or unindexed press releases.

Biggest Losers

Wed, Sep 2, 2026 50

EYES

Second Sight Medical Products Inc

$1.42−$27.67

-95.1%

ADBT

Advasa Holdings, Inc.

$1.72−$2.07

-56.1%

TCRX

TScan Therapeutics, Inc.Healthcare

$0.39−$0.28

-41.9%

NASDAQ · Mkt cap $49 M

TScan Therapeutics announced a 75% workforce reduction and strategic pivot to focus solely on solid tumor cell therapy programs, triggering a sharp selloff as investors reacted to the dramatic restructuring and implied loss of confidence in prior directions.

The company disclosed a major strategic reorganization on September 2, 2026, cutting 75% of its workforce while narrowing its pipeline focus to in vivo-engineered TCR-T therapies for solid tumors. While the announcement includes some positive elements—advancement of two candidates to IND-enabling studies and updated Phase 1 ALLOHA data showing 100% response in Cohort C—the magnitude of the layoff and portfolio contraction appears to have overwhelmed any near-term clinical optimism. A 75% workforce reduction typically signals either severe cash constraints, a loss of investor/board confidence in the previous strategy, or both. The market's 41.92% single-day drop suggests investors interpret this as a material strategic failure requiring drastic action rather than a positive clinical refocus. The timing and scale of restructuring, not the clinical data itself, appears to be the primary driver of selling pressure.

CUEN

Cuentas Inc.Technology

$0.30−$0.20

-39.8%

NASDAQ · Mkt cap $5.4 M

No news headlines were found in the last 48 hours for CUEN, so the 39.80% single-day drop cannot be attributed to a specific public announcement; the cause likely falls into categories such as technical selling, market sentiment shift, or delayed news not yet indexed.

The absence of recent news headlines for CUEN makes it impossible to tie the sharp decline to a specific corporate event. Given that CUEN trades at a very low price of $0.30, it may be a microcap or distressed name subject to higher volatility and liquidity constraints. For stocks in this category, sharp single-day moves often reflect technical factors such as stop-loss cascades, short covering reversals, options expiration activity, or shifts in sentiment among retail or speculative traders. It is also possible that material news was released but has not yet been indexed by the RSS feeds checked, or that the move reflects accumulated negative sentiment from earlier in the week. Without access to the company's filings, social media chatter, or intraday flow data, attributing the decline to any specific catalyst would be speculation.

WYTC

WYTEC INTERNATIONAL INC

$0.91−$0.54

-37.2%

NASDAQ

No news headlines were available in the last 48 hours, so the 37% drop cannot be attributed to a specific announced event. The decline is likely driven by technical selling, market sentiment shifts, or undisclosed corporate developments.

WYTEC International experienced a severe single-day loss of 37%, ranking it among the day's worst performers, yet no news headlines appeared in the last 48 hours to explain the move. This disconnect between magnitude and news availability is notable. For a micro-cap NASDAQ stock trading near $0.91, sharp moves can occur due to thin liquidity, short covering reversals, or delayed disclosure of material events not yet syndicated through major news feeds. Possible categories of catalyst include unexpected earnings results, insider selling, regulatory filings, or dissolution concerns, but without corroborating headlines these remain speculative. The lack of any news headline is itself suggestive that either the move preceded formal disclosure, or the triggering event was communicated through channels outside mainstream financial news.

CDT

Conduit Pharmaceuticals IncHealthcare

$0.91−$0.49

-35.0%

KCAC.WT

$0.79−$0.41

-34.2%

TANH

Tantech Holdings LtdConsumer Defensive

$0.23−$0.10

-30.5%

NASDAQ · Mkt cap $5.6 M

Tantech announced a reverse stock split approved by its board on September 1st, which typically signals financial distress and often triggers sharp selling as existing shareholders face dilution and valuation reset.

The headline confirms that Tantech's board approved a reverse stock split, with the record date announced on September 1st. Reverse splits are commonly executed by companies facing delisting risk due to low stock price, and the market reaction of negative 30.45% suggests investors view this as a negative signal about the company's financial health and future prospects. The timing aligns closely with the price decline. However, the headline snippet is truncated and does not specify the exact split ratio, the effective date, or any management commentary about the company's financial condition, so we cannot determine whether additional negative context was provided in the full announcement. The sharp drop is consistent with typical investor sentiment toward reverse splits, but we lack detail on whether other factors contributed.

SVVC

Firsthand Technology Value Fund IncFinancial Services

$0.01−$0.00

-30.0%

NASDAQ · Mkt cap $49 K

No news headlines were found in the last 48 hours, so the 30% drop in SVVC cannot be directly attributed to a reported event. The move likely reflects technical selling, fund liquidation pressures, or delayed market reaction to an earlier announcement not captured in this news window.

SVVC is a closed-end investment fund focused on early-stage technology companies, a category that can be volatile and illiquid, especially at very low price levels. With no recent headlines provided, the sharp 30% drop cannot be tied to a specific earnings miss, portfolio action, or policy change announced in the last 48 hours. Possible structural causes include forced selling due to fund redemptions or share buybacks, technical breakdown at a key support level given the stock's already-depressed valuation near a penny, or a delayed market repricing following an earlier announcement or unfavorable earnings/NAV update. Without access to the fund's recent NAV performance, holdings, or any press releases, attribution remains speculative.

WETO

Webus International Limited Ordinary SharesTechnology

$3.93−$1.73

-29.8%

NASDAQ · Mkt cap $11 M

WETO fell 29.85% on September 2nd despite two nearly identical press releases on September 1st announcing a sEMG-Vision robotics demonstration; the disconnect between positive technology news and sharp sell-off suggests the move was likely driven by factors unrelated to the headlines or reflected…

The two recent headlines both describe Wetour Robotics' demonstration of a sEMG-Vision system for physical AI training, emphasizing a dual-modal approach combining muscle-activity sensing and vision. These are substantive technology announcements with positive framing, yet the stock experienced the tenth-largest single-day loss on the exchange. This mismatch between news tone and price action suggests either the market did not view the announcement as material or market-moving, or the decline was driven by separate catalysts not captured in the provided headlines. Robotics and AI training companies often trade on sentiment and funding dynamics; the sell-off could reflect profit-taking, short covering, sector rotation, valuation concerns, or undisclosed corporate or market-wide developments unmentioned in the RSS feed snapshot.

SDST

Stardust Power Inc.Industrials

$0.25−$0.11

-29.4%

NASDAQ · Mkt cap $8.6 M

No news headlines were published in the last 48 hours for SDST, so the 29% drop on September 2 cannot be traced to any identified company announcement or reported event.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst for the sharp decline. However, a 29% single-day loss in a micro-cap stock trading at $0.25 typically reflects one of several common scenarios: a delayed negative announcement that broke outside the RSS feed window, technical selling or margin liquidation in a thinly traded security, sector-wide weakness in energy or power stocks, short-seller activity, or a rumor circulating on social media or message boards that has not yet been formally reported. Stardust Power operates in the renewable or power generation space, which can be sensitive to energy policy shifts or commodity moves. Without contemporaneous headlines, any specific explanation would be speculation rather than analysis.

TWLVR

Twelve Seas Investment Company III Rights

$0.09−$0.04

-28.4%

NASDAQ

No news headlines were found in the last 48 hours to explain the 28.4% decline in TWLVR, a blank-check company rights offering with typically low liquidity and price volatility.

The absence of any recent news headlines makes it impossible to pinpoint a specific catalyst for the sharp drop. However, TWLVR is a rights offering from a SPAC (special purpose acquisition company), which is a structural type of security that experiences outsized price swings on minimal trading volume due to extremely low liquidity. Rights offerings are often the lowest-liquidity tier of SPAC-related instruments and can gap sharply on thin trades unrelated to fundamental news. The 28.4% move could reflect a single large sell order, an options expiration effect, portfolio rebalancing, or deteriorating sentiment toward blank-check vehicles generally, rather than company-specific news. Without headlines or volume context, identifying the true driver is speculative.

IMC

IMC Rare Earths LtdBasic Materials

$6.54−$2.36

-26.5%

NYSE · Mkt cap $1.1 B

IMC Rare Earths fell 26.52% with no news in the last 48 hours, suggesting the drop was driven by market-wide selling, technical breakdown, or undisclosed company-specific developments not yet reflected in public headlines.

No headlines were available in the last 48 hours to explain this sharp decline. IMC Rare Earths operates in the rare earths sector, which is cyclical and sensitive to geopolitical developments, commodity prices, trade policy shifts, and broader industrial demand. A 26.52% single-day drop in a stock of this type without accompanying news could reflect several plausible scenarios. First, the broader market or the materials/energy sector may have experienced sharp selling pressure, with this stock amplifying that move due to lower liquidity or leverage. Second, negative rumors or analyst downgrades not yet captured in Yahoo Finance RSS could have circulated. Third, company-specific news such as disappointing production data, project delays, financing issues, or management changes may have been announced through channels not yet indexed. Fourth, technical factors such as stop-loss cascades or options expiration mechanics could have accelerated the decline. Without substantive news coverage, the precise catalyst remains opaque.

XPL

Solitario Zinc Corp

$0.58−$0.19

-25.0%

INAQ

INSU Acquisition Corp. II

$2.08−$0.69

-24.9%

BESS.WT

$1.13−$0.37

-24.7%

COPR.WT

$1.50−$0.49

-24.6%

AMOD

Insight Acquisition Corp.Technology

$2.10−$0.68

-24.5%

NASDAQ · Mkt cap $22 M

No news headlines were found in the last 48 hours to explain AMOD's sharp 24.46% drop, so the cause remains unclear without additional context on company developments or market conditions.

Insight Acquisition Corp. (AMOD) is a SPAC with no recent news coverage in the provided sources, yet it suffered a significant single-day decline. For blank-check companies, typical catalysts include failed merger negotiations, redemption announcements, extension votes, insider selling disclosures, or deteriorating conditions at a target company under LOI. Without headline evidence, the most probable categories are either a material corporate action (merger termination, adverse shareholder vote, or extension deadline approaching) or technical selling tied to SPAC-specific pressures such as high redemption rates or a deadline-driven sell-off. The magnitude of the decline suggests a concrete event rather than random volatility, but the absence of news means the specific trigger cannot be confirmed from the available sources.

APUS

Apimeds Pharmaceuticals US, IncHealthcare

$2.71−$0.83

-23.4%

NYSE · Mkt cap $6.0 M

No news headlines were found in the last 48 hours to explain APUS's 23.45% decline, so the cause remains unclear without additional context such as earnings, guidance, regulatory action, or market-wide factors.

The absence of any recent news headlines in the Yahoo Finance RSS feed makes it impossible to identify a specific catalyst for the sharp 23.45% drop. For a small-cap pharmaceutical stock like APIMEDS, typical drivers of single-day losses of this magnitude include adverse clinical trial results, FDA regulatory action or rejection, missed earnings expectations, guidance reductions, insider selling, analyst downgrades, or sector-wide selloffs. It is also possible the move reflects delayed disclosure of information, technical selling in a thinly traded security, or broader market stress affecting micro-cap equities. Without access to company filings, earnings calls, press releases, or detailed intraday trading data, no specific mechanism can be identified from the available evidence.

IRHOR

Iron Horse Acquisitions Corp. II Rights

$0.15−$0.04

-22.6%

NASDAQ

Iron Horse Acquisition II was selected by Mooving for a battery intelligence partnership announced on September 1st, yet the rights security fell 22.56% the next day, suggesting market skepticism about deal terms, SPAC merger structure, or broader sentiment headwinds rather than enthusiasm from t…

The headline from September 1st announces a positive strategic selection: ELECTRA AI and Iron Horse Acquisition II chosen by Mooving to power battery intelligence for a battery-swapping network. On the surface this appears constructive for a blank-check acquisition vehicle seeking to merge with an operating company. However, the stock declined sharply the following day, which is counterintuitive. This suggests either that investors viewed the deal terms as unfavorable, that the Mooving partnership itself carries execution risk or limited revenue visibility, or that broader market conditions for SPACs and battery technology plays have deteriorated. Rights offerings are junior equity claims and highly sensitive to redemption risk and sponsor confidence, so any doubt about merger certainty or deal value can trigger outsized losses. The disconnect between positive news and sharp selling indicates the market is pricing in skepticism rather than confidence in this transaction's value creation.

LABT

Lakewood-Amedex Biotherapeutics Inc.Healthcare

$2.09−$0.60

-21.8%

NASDAQ · Mkt cap $3.8 M

No news headlines were published in the last 48 hours about LABT, so the cause of the 21.85% drop cannot be determined from the available evidence; this type of biotech stock typically moves on clinical trial results, regulatory decisions, or funding announcements.

The absence of any Yahoo Finance headlines in the 48 hours preceding the drop is notable and limits confidence in pinpointing the catalyst. For a small-cap biotech like Lakewood-Amedex, a decline of this magnitude typically correlates with negative clinical data, an FDA rejection or clinical hold, loss of financing, insider selling, or an adverse analyst downgrade. It is also possible the move resulted from a press release or company announcement that has not yet been indexed by Yahoo's feed, or from broader market volatility in the biotech sector on September 2, 2026. Without access to LABT's investor relations channel, SEC filings, or real-time trading commentary, the specific trigger remains unknown. Intraday technical selling or short covering could also explain the move, but these would be secondary to an underlying catalyst.

UPC

Universe Pharmaceuticals INCHealthcare

$4.80−$1.21

-20.5%

NASDAQ · Mkt cap $3.5 M

Universe Pharmaceuticals shares surged 22.6% premarket but then reversed sharply to close down 20.47%, suggesting the premarket rally lacked a credible catalyst and traders sold into the gains during regular hours.

The sole news item reports that UPC shares rose 22.6% premarket on 2026-09-02 with no new catalyst identified. This is a critical detail: the morning rally was unexplained. The subsequent intraday reversal to a 20.47% loss by close indicates that investors either recognized the premarket move as unfounded, took profits, or reacted to information that emerged after market open that was not captured in the Yahoo Finance headlines provided. Without additional news items explaining the morning surge or the afternoon decline, the most likely categories are: a short squeeze or technical bounce that unwound, an unconfirmed rumor that failed, or a delayed public announcement (earnings, clinical results, regulatory action) that arrived during regular trading hours but was not included in the headline feed available to this analysis.

LTCH

Latch, Inc.Technology

$0.15−$0.04

-20.3%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours to explain Latch's 20% drop, so the catalyst remains unknown; the decline likely stems from technical selling, sector rotation, or undisclosed developments.

Latch experienced a sharp 20% single-day decline to $0.15 per share with no corresponding news coverage in the Yahoo Finance RSS feed over the prior 48 hours. This absence of explanatory headlines makes root-cause attribution difficult. For a micro-cap smart-lock and access-control company trading at this price level, typical catalysts would include quarterly earnings misses, cash runway concerns, competitive announcements, or executive departures. Alternatively, the move could reflect technical weakness from a prior spike, algorithmic selling in a thinly traded security, or a delayed market reaction to a development not yet covered in major news wires. Without accompanying headlines or specific corporate events, we cannot isolate the trigger with confidence.

BTAI

Bioxcel Therapeutics IncHealthcare

$0.11−$0.03

-19.8%

NASDAQ · Mkt cap $26 M

No news headlines were found in the last 48 hours, so the 19.78% drop cannot be attributed to a specific announced event; the decline likely reflects broader biotech sector weakness, technical selling, or undisclosed developments.

Bioxcel Therapeutics is a small-cap biotech company trading at an extremely depressed price of $0.11, which places it in penny-stock territory. The absence of any news headlines in the past 48 hours means no specific catalyst—such as an earnings miss, FDA action, clinical trial failure, financing announcement, or guidance cut—can be identified from public sources. For a stock at this price level and market cap, common drivers of sharp declines include generic sector rotation away from biotech, forced liquidations or margin calls, deteriorating cash position concerns, dilutive capital raises, failed clinical data that circulates before formal announcement, or short-seller activity. Without structural insights into BTAI's specific situation (cash runway, pipeline status, debt position), we cannot distinguish between these scenarios. The magnitude of the move suggests material negative information may be in circulation, but verification from official sources is not available.

CISS

C3is Inc. - Common StockIndustrials

$1.40−$0.32

-19.4%

NASDAQ · Mkt cap $4.6 M

No news headlines were found in the last 48 hours, so the 19.39% drop cannot be attributed to any specific announced event. The decline likely reflects technical selling, market-wide pressure, or undisclosed company developments.

The absence of any news headlines in the Yahoo Finance RSS feed over the last 48 hours means we cannot tie this sharp single-day drop to a concrete catalyst such as earnings, guidance revision, regulatory action, or contract announcement. C3is Inc. is a small-cap NASDAQ stock trading at $1.40, and stocks in this category are prone to liquidity-driven moves, momentum-based selling, and reactions to rumors or internal developments that may not immediately appear in mainstream news feeds. Without additional context about the company's fundamentals, cash position, clinical or commercial status (if applicable), or recent insider activity, the move remains unexplained by the evidence at hand. The rank as the 25th biggest loser suggests broad-based selling pressure rather than a targeted negative catalyst, though that too is inference.

AIIO

NWTN Inc.Consumer Cyclical

$1.69−$0.36

-17.6%

NASDAQ · Mkt cap $487 M

Robo.ai announced strong June-August revenue of over US$180 million following its QC Capital acquisition, yet the stock fell 17.56%, suggesting the market either viewed the headline numbers as disappointing relative to expectations, or concerns about the acquisition's integration or dilution outw…

The headline reports a positive development: Robo.ai disclosed revenue exceeding US$180 million for a three-month period post-acquisition. However, a 17.56% single-day drop despite what appears to be a constructive announcement points to a disconnect between what was announced and market expectations. This could reflect several scenarios: the market expected substantially higher revenue given the acquisition, management's full statement may have contained cautionary language or lowered forward guidance not captured in the headline, investor concerns about acquisition integration or balance sheet impact, or a technical/momentum reversal unrelated to fundamentals. Without access to the full earnings release, conference call details, or historical analyst expectations, it is difficult to pinpoint whether the revenue figure itself was the disappointment or whether other elements of the announcement drove the selloff.

KLXER

KLX Energy Services Holdings, Inc. Rights

$0.11−$0.02

-17.3%

GSUN

Golden Sun Education Group LimitedConsumer Defensive

$0.22−$0.05

-17.1%

NASDAQ · Mkt cap $3.5 M

No news headlines were found in the last 48 hours, so the 17% drop cannot be tied to a disclosed event; the cause likely stems from technical selling, a delayed or unannounced corporate action, or broader market conditions affecting small-cap stocks.

Golden Sun Education Group (GSUN) declined 17.11% with zero news coverage in the preceding two days according to the available RSS feed. This absence of headline explanation is notable for a stock ranked among the day's 28 biggest losers. For micro-cap or lower-liquidity education stocks trading near $0.22, typical catalysts include negative earnings surprises, shareholder dilution announcements, regulatory concerns in the education sector, insider selling, or technical breakdown through support levels. It is also possible an announcement was made outside the monitored news sources, or that trading volume concentrated in a thin float amplified a modest selloff into a large percentage move. Without disclosed information, attribution remains speculative and confined to general categories of risk that apply to this security class.

PMAX

Powell Max Limited Class A Ordinary SharesFinancial Services

$0.80−$0.16

-16.5%

NASDAQ · Mkt cap $2.1 M

No news headlines were found in the last 48 hours to explain PMAX's 16.48% decline, so the cause remains unclear; the drop may reflect technical selling, sector weakness, or undisclosed company-specific developments.

No recent news headlines from Yahoo Finance are available to explain the sharp 16.48% drop in PMAX stock on September 2, 2026. Without access to earnings reports, guidance changes, regulatory actions, or other corporate announcements, we cannot identify a specific catalyst for this move. For a micro-cap or low-priced stock like PMAX trading at $0.80, significant single-day declines can be driven by several common factors: thin liquidity amplifying price swings, short-seller activity or rumors undetected in mainstream headlines, sector-wide selling pressure, technical breakdown through support levels, or delayed disclosure of negative company news not yet reflected in major news feeds. The absence of news does not mean no catalyst exists—it may simply mean the catalyst has not yet surfaced in public announcements or widely-distributed reporting.

NCRA

Nocera Inc.Consumer Defensive

$1.94−$0.38

-16.4%

NASDAQ · Mkt cap $3.2 M

No news headlines were reported in the last 48 hours for NCRA, so the 16.38% drop likely stems from a delayed announcement, technical selling, broader market weakness, or company-specific developments not yet reflected in major news feeds.

The absence of any news headlines in the 48-hour window preceding this sharp 16.38% decline is notable and limits causal inference. For a small-cap stock trading under $2.00, moves of this magnitude can be driven by several mechanisms: delayed or after-hours earnings releases, press releases issued outside standard news aggregation timing, technical breakdown of support levels triggering algorithmic selling, short-squeeze reversals, or sector-wide pullbacks in micro-cap equities. Without access to the company's investor relations announcements, SEC filings filed on the snapshot date, or real-time trading activity, any specific attribution remains speculative. The stock's rank as the 30th biggest loser suggests this was a meaningful market-wide or sector-specific event rather than isolated retail movement.

XTIA

XTI Aerospace, Inc.Industrials

$0.95−$0.19

-16.3%

NASDAQ · Mkt cap $51 M

XTI Aerospace received a Nasdaq deficiency notice on August 31st, likely triggering the 16% drop on September 2nd as investors reacted to compliance concerns that could threaten the company's listing status.

The headline explicitly states that XTI Aerospace announced receipt of a Nasdaq deficiency notice on August 31st, 2026. Although the full text of the announcement is truncated in the provided headline, a deficiency notice from Nasdaq typically indicates the company has failed to meet one or more listing standards—commonly minimum bid price requirements, stockholder equity thresholds, or market capitalization minimums. Such notices create material uncertainty about continued exchange listing and trigger automatic investor concern about delisting risk, which substantially increases the cost of capital and liquidity. The 16% decline on September 2nd (trading day following the announcement) represents a direct market reaction to this regulatory warning. No other news items are provided that would compete as alternative explanations.

PSQL

Pasqal Holding SA

$12.19−$2.39

-16.1%

ACTU

Actuate Therapeutics, Inc.Healthcare

$1.31−$0.25

-15.8%

NASDAQ · Mkt cap $24 M

No news headlines were published in the last 48 hours about ACTU, so the 15.81% decline likely stems from a clinical setback, insider selling, broader biotech weakness, or market technical factors not yet reflected in available headlines.

Actuate Therapeutics is a clinical-stage biotech company, and no news has appeared in the Yahoo Finance RSS feed within the last two days to explain the sharp 15.81% single-day drop. For early-stage therapeutic companies, large intraday declines often correlate with clinical trial results, regulatory feedback, management changes, or sector-wide selloffs in small-cap biotechs. The absence of a headline does not mean no catalyst occurred—news may be delayed in propagation, announced after market close, or disseminated through channels outside the RSS feed monitored here. Alternatively, the move could reflect technical selling, options expiration effects, or accumulated negative sentiment that finally triggered sell orders. Without corroborating information, we cannot pinpoint the specific trigger.

FCEL

FuelCell Energy IncIndustrials

$14.40−$2.68

-15.7%

NASDAQ · Mkt cap $1.2 B

FuelCell Energy reported Q3 2026 earnings on September 2 with revenue down 29% year-over-year to $33 million, missing analyst estimates of $38.8 million, and posted a wider-than-expected net loss of $44.47 million, triggering the 15.69% stock decline despite positive announcements around data cen…

The stock decline is directly tied to FuelCell Energy's Q3 2026 earnings results released on September 2. The company reported revenue of $33 million, representing a 29% decline from the prior year and falling below Wall Street's consensus estimate of $38.8 million. More significantly, the company posted a net loss of $44.47 million, which multiple sources characterize as wider than expected. The revenue miss was attributed to fewer module deliveries to South Korea and lower generation output. While management highlighted positive developments including landmark data center reservation agreements, a strong cash position of $737.3 million, and a 100-megawatt production capacity target by October 2026, these forward-looking initiatives were insufficient to offset the disappointing current-period financial performance and unexpected charges that surprised the market.

QUMSR

Quantumsphere Acquisition Corp. Rights

$0.08−$0.02

-15.3%

RDIB

Reading International IncCommunication Services

$15.09−$2.72

-15.3%

NASDAQ · Mkt cap $204 M

No news headlines were found in the last 48 hours for RDIB, so the 15.27% drop cannot be attributed to a disclosed event. The decline likely reflects sector weakness, technical selling, or an undisclosed development.

Reading International Inc traded down over 15% on September 2 with zero news coverage in the prior 48 hours according to the provided feed. This disconnect between a substantial single-day loss and absence of headline catalysts is common for smaller-cap or lower-liquidity names. RDIB operates movie theaters and entertainment venues, a sector historically sensitive to consumer spending, interest rates, and competitive pressures from streaming. Possible explanations include sector-wide repricing, a delayed earnings miss or guidance cut that hasn't yet surfaced in this feed, technical support breakdown, or after-hours news from an alternate source not captured here. Without additional information, attribution remains speculative.

HKPD

HONG KONG PHARMA DIGITAL TECHNOLOGY HOLDINGS LIMITEDHealthcare

$0.15−$0.03

-15.2%

NASDAQ · Mkt cap $3.9 M

No news headlines were found in the last 48 hours, so the 15% drop cannot be directly attributed to a specific announcement or event; the cause remains unknown but could involve market sentiment, technical factors, or untracked developments.

Yahoo Finance returned no headlines for HKPD in the last 48 hours despite the stock ranking as the 37th biggest loser of the day with a sharp 15.15% decline. Without news coverage, it is difficult to pinpoint a concrete catalyst. Possible explanations could include technical selling or momentum reversal in a low-volume microcap stock, sector-wide weakness in biotech or digital health, short-term profit-taking after a prior rally, or negative information disseminated through channels not captured in mainstream RSS feeds. Microcap stocks listed on major exchanges sometimes experience large intraday swings with minimal news simply due to thin liquidity and retail trading activity. Without headline support or access to filing alerts or social media trends, attribution remains speculative.

JACS.RI

Jackson Acquisition Company II

$0.07−$0.01

-15.0%

BPTH

Bio-Path Holdings Inc

$0.02−$0.00

-14.9%

Missfresh LimitedCommunication Services

$13.42−$2.15

-13.8%

NASDAQ · Mkt cap $27 M

No news headlines were found in the last 48 hours for MF, so the 13.81% drop cannot be attributed to a specific disclosed event. The decline likely stems from technical selling, market-wide pressure, or undisclosed developments.

No recent news headlines are available to explain the sharp 13.81% decline in MF stock. Without disclosed catalysts such as earnings misses, guidance cuts, competitive developments, or operational challenges, determining the precise cause is difficult. For a company like Missfresh Limited, a fresh food e-commerce platform, typical pressure points include unit economics concerns, cash burn rates, competitive intensity in grocery delivery, or changes in investor sentiment toward the sector. The stock's 40 ranking as a daily loser suggests broad selling interest rather than isolated or rumor-driven moves, but without news or structural context, the underlying driver remains unclear. Market-wide volatility or technical breakdown below key support levels could also account for the move.

MDB

MongoDB IncTechnology

$375.29−$60.00

-13.8%

NASDAQ · Mkt cap $34 B

MongoDB beat earnings estimates and raised guidance, but the stock crashed 13.78% because Atlas revenue growth stalled at the same pace for a third consecutive quarter, disappointing investors who expected acceleration in the company's core cloud product.

The headlines establish a clear "sell-the-news" pattern. MongoDB delivered a clean beat—revenue grew 30.5% year-over-year, earnings exceeded estimates, and fiscal 2027 guidance was raised. However, the market is fixated on a single metric buried in the results: Atlas, the flagship cloud-native database product, grew at an identical rate for three straight quarters, signaling no acceleration. Investors had priced in an inflection point in Atlas growth, and the lack of one triggered a sharp repricing. The CEO acknowledged this disconnect in a CNBC interview, noting that Atlas growth acceleration could be "a few quarters away," which implicitly confirms the market's disappointment was justified. This is a classic case of beating consensus while missing the forward growth narrative the stock already embodied.

DAIC

CID HoldCo, Inc.Technology

$3.08−$0.47

-13.4%

NASDAQ · Mkt cap $508 K

No news headlines were found in the last 48 hours, so the 13.35% drop cannot be tied to any announced event; the cause likely falls into technical selling, market-wide pressure, or undisclosed company developments.

The absence of recent news headlines makes it impossible to pinpoint a specific catalyst for DAIC's sharp 13.35% decline on September 2, 2026. This stock ranks as the 42nd biggest loser of the day, indicating meaningful selling pressure. For a smaller-cap holding company like CID HoldCo, typical drivers of single-day moves include earnings disappointments or guidance misses (if released outside the news feed captured here), sector rotation, broader market declines affecting leveraged or illiquid securities disproportionately, short covering or squeeze dynamics, or private information circulating before formal announcement. Without access to intraday trading volume, short interest data, or market-wide performance context for that date, it is unclear whether this was company-specific or part of a broader downturn. The lack of any disclosed news suggests either a technical/algorithmic move or a delay in news indexing.

KIDZ

Classover Holdings, Inc. Class B Common StockConsumer Defensive

$3.70−$0.54

-13.2%

BTOG

Bit Origin LtdFinancial Services

$2.27−$0.34

-13.0%

NASDAQ · Mkt cap $3.6 M

No news headlines were found in the last 48 hours, so the 13% drop likely reflects either a delayed market reaction to an earlier event, sector weakness, or a technical/momentum reversal unconnected to public company announcements.

The absence of recent news makes it difficult to pinpoint a specific catalyst. BTOG is a cryptocurrency mining and blockchain company, sectors historically prone to sharp price swings driven by bitcoin movements, regulatory sentiment, energy costs, or hardware availability rather than company-specific announcements. The stock could have dropped due to a broader crypto market decline, a delayed reaction to earlier news not captured in the 48-hour window, or negative sentiment around mining profitability. Alternatively, the move may reflect technical factors such as option expiration, short covering, or momentum selling in a lower-liquidity name. Without recent headlines or context about the company's recent performance, only generic hypotheses are available.

NUR

Nuran Wireless Inc.

$1.90−$0.28

-13.0%

QETAR

Quetta Acquisition Corporation

$0.49−$0.07

-12.6%

EWAVR

East West Ave Acquisition Corp. Rights

$0.14−$0.02

-12.5%

REA

Rare Earths Americas, Inc.

$12.03−$1.66

-12.1%

STDN

Standard Nuclear, Inc.Basic Materials

$14.65−$1.92

-11.6%

NYSE · Mkt cap $2.4 B

No headlines were found in the last 48 hours explaining the 11.59% decline in STDN stock, so the cause remains unclear without additional market intelligence or company disclosures.

Standard Nuclear is a nuclear energy infrastructure company, and an 11-point drop with no news in the headline feed suggests either a delay in news dissemination to the RSS feed, a technical or sector-wide pullback, or an unannounced development. Nuclear stocks can be sensitive to regulatory announcements, project delays, financing updates, or shifts in energy policy. Given that STDN ranked as the 49th biggest loser of the day, it is possible the broader market or nuclear sector experienced pressure, or the company released material information through a channel not yet indexed by Yahoo Finance. Without direct evidence from earnings, guidance, contracts, or regulatory filings, attribution remains speculative.

GIII

G-III Apparel Group LtdConsumer Cyclical

$28.45−$3.72

-11.6%

NASDAQ · Mkt cap $1.2 B

G-III beat Q2 earnings, raised full-year EPS guidance, and completed the Marc Jacobs acquisition, yet fell 11.56%—an unusual disconnect suggesting investor concern over execution risk, valuation, or forward sales headwinds despite improved profitability.

G-III delivered an unambiguously positive earnings event on September 2nd: Q2 EPS beat guidance at $0.46 versus $0.25 prior year, gross margins expanded significantly, the company raised fiscal 2027 EPS guidance, and the strategic Marc Jacobs acquisition closed. By typical market logic, this should have driven the stock higher. Instead it fell sharply. The most likely explanations are that Q2 revenue missed (down 2.86%) despite margin expansion, raising questions about organic growth trajectory; that the Marc Jacobs acquisition itself is viewed as dilutive or risky in execution despite its strategic appeal; that management guidance on forward sales (reaffirmed rather than raised) signals demand caution; or that the stock had run up into earnings and this is profit-taking after an initial rally. Without forward guidance specifics or investor commentary, we cannot definitively isolate which concern dominated, but the positive earnings did not override a bearish narrative investors clearly held heading into or during the announcement.